{
    "clinical_study": {
        "@rank": "107679", 
        "acronym": "OCCLUDE-I", 
        "arm_group": [
            {
                "arm_group_label": "Cohort A", 
                "description": "Varicocele arising from the spermatic vein(s) and pampiniform plexus, with or without concomitant diagnosis of infertility or subfertility"
            }, 
            {
                "arm_group_label": "Cohort B", 
                "description": "Pelvic varices in females for the treatment of pelvic congestion syndrome (e.g., pelvic venous incompetence)."
            }
        ], 
        "brief_summary": {
            "textblock": "To collect confirmatory data in support of the safety and performance of the ArtVentive\n      Medical Group Endoluminal Occlusion System."
        }, 
        "brief_title": "Evaluation of PerformanCe of the Peripheral EOS in the Treatment of Varicocele or Pelvic Congestion SynDromE", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Varicocele", 
            "Pelvic Congestion Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": "Varicocele"
        }, 
        "detailed_description": {
            "textblock": "Prospective, non-randomized, multi-center confirmatory observational study for the treatment\n      of subjects with the need for vascular occlusion for the following conditions:\n\n        1. Cohort A:  Varicocele arising from the spermatic vein(s) and pampiniform plexus, with\n           or without concomitant diagnosis of infertility or subfertility\n\n        2. Cohort B:  Pelvic varices in females for the treatment of pelvic congestion syndrome\n           (e.g., pelvic venous incompetence)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects aged \u226518 to \u226475 years.\n\n          2. Subject with target vessels of 3.0 mm to 12.0 mm in diameter.\n\n          3. Subject having indications to undergo embolotherapy consistent with clinical and\n             pre-procedural angiographic assessment for spermatic vein origin varicocele\n             (unilateral and/or bilateral) or pelvic congestion syndrome (pelvic venous\n             incompetence).\n\n          4. Subject is able and willing to comply with site standard medical follow-up, including\n             one month follow-up visit.\n\n          5. Subject or subject's legal representative have been informed of the nature of the\n             study, agrees to participate and has signed the consent form.\n\n        Exclusion Criteria:\n\n          1. Subject has an active systemic infection.\n\n          2. Subject has a known allergy to iodinated contrast for which they cannot be adequately\n             premedicated.\n\n          3. Subject has history of stroke within the prior 6 months.\n\n          4. Subject has history of myocardial infarction with the prior 3 months.\n\n          5. Subject has acute or chronic renal disease (e.g., as measured by a serum creatinine\n             of >2.5 mg/dL or >220 umol/L), or on dialysis.\n\n          6. Subject has a known coagulopathy or has a bleeding diatheses, thrombocytopenia with\n             platelet count less than 100,000/microliter, or INR >1.5.\n\n          7. Co-morbid conditions that place the subject at an unacceptable surgical risk (e.g.,\n             severe chronic obstructive pulmonary disease, hepatic failure, cardiac disease,\n             autoimmune disorders or conditions of severe immunosuppression).\n\n          8. Subjects in whom venography or arteriography is contraindicated.\n\n          9. Subjects with known hypersensitivity or contraindication to nickel or nitinol.\n\n         10. Subject has a less than one year life expectancy.\n\n         11. Subject is pregnant or breastfeeding.\n\n         12. Subject with endometriosis or other ovarian / uterine pathology with adhesions that\n             would interfere with the endpoints of this study.\n\n         13. Subject with previous pelvic surgical intervention or embolotherapy for varicocele or\n             ovarian varices that would interfere with the endpoints of this study, including but\n             not limited to, recurrent varicocele or ovarian varices.\n\n         14. Any clinical evidence that the investigator feels would place the subject at\n             increased risk with the deployment of the device.\n\n         15. Subject has planned concomitant procedure at the time of the embolization (e.g., coil\n             embolization, etc.).\n\n         16. Subject is participating in another study of a device, medication, biologic, or other\n             agent within 30 days or could, in the opinion of the investigator, impact the results\n             of this study.\n\n         17. Subject has other medical, social or psychological problems that in the opinion of\n             the investigator would preclude them from receiving this treatment and the procedures\n             and or participating in evaluations pre- and post-treatment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects requiring permanent occlusion of the peripheral vessels for the following\n        conditions:\n\n          1. Cohort A:  Varicocele arising from the spermatic vein(s) and pampiniform plexus, with\n             or without concomitant diagnosis of infertility or subfertility.\n\n          2. Cohort B:  Pelvic varices in females for the treatment of pelvic congestion syndrome\n             (e.g., pelvic venous incompetence)."
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033863", 
            "org_study_id": "TD 0080/03"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Varicocele", 
            "Pelvic Congestion Syndrome", 
            "Pelvic Venous Incompetence", 
            "Ovarian Varices"
        ], 
        "lastchanged_date": "January 10, 2014", 
        "location": [
            {
                "contact": {
                    "email": "geert.maleux@uzleuven.be", 
                    "last_name": "Geert Maleux, Prof. Dr.", 
                    "phone": "+32 16 34 37 82"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "UZ Leuven"
                }, 
                "investigator": {
                    "last_name": "Geert Maleux, Prof Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "tojarg@interia.pl", 
                    "last_name": "Thomas Jargiello, Prof Dr", 
                    "phone": "+48 81 72 44 154"
                }, 
                "facility": {
                    "address": {
                        "city": "Lubin", 
                        "country": "Poland"
                    }, 
                    "name": "University Hospital No4"
                }, 
                "investigator": {
                    "last_name": "Thomas Jargiello, Prof Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "vcarvalheiro@netcabo.pt", 
                    "last_name": "Vitor Carvalheiro, MD", 
                    "phone": "+351 910 261 858"
                }, 
                "facility": {
                    "address": {
                        "city": "Coimbra", 
                        "country": "Portugal"
                    }, 
                    "name": "Centro Hospitalar e Universit\u00e1rio de Coimbra, E.P.E."
                }, 
                "investigator": {
                    "last_name": "Vitor Carvalheiro, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "os.vandenberg@eoc.ch", 
                    "last_name": "Josua Van den Berg, Prof", 
                    "phone": "+41 91 811 60 72"
                }, 
                "facility": {
                    "address": {
                        "city": "Lugano", 
                        "country": "Switzerland"
                    }, 
                    "name": "Ospedale Regionale di Lugano"
                }, 
                "investigator": {
                    "last_name": "Josua Van den Berg, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Poland", 
                "Portugal", 
                "Switzerland"
            ]
        }, 
        "number_of_groups": "2", 
        "official_title": "PrOspective, MultiCenter Study for the Evaluation of PerformanCe of the ArtVentive Medical Group Peripheral EndoLuminal OcclUsion SystemTM in the Treatment of Varicocele or Pelvic Congestion SynDromE - OCCLUDE I", 
        "overall_official": {
            "affiliation": "UZ Leuven, Belgium", 
            "last_name": "Geert Maleux, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Portugal: Health Ethic Committee", 
                "Poland: Ethics Committee", 
                "Switzerland: Ethikkommission"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Composite of new-onset major device-related adverse event(s) including device embolization beyond targeted treatment area (not therapeutic indication of embolization), need for emergency surgical intervention of the target vessel, or distal embolization (non-device embolization, e.g., particulate matter / plaque distal to the device) at 30 days.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "Acute & 30 days"
        }, 
        "reference": {
            "PMID": "23703667", 
            "citation": "Venbrux AC, Rudakov L, Plass A, Emmert MY, Ebner A. A New Occlusion Device: Application of the ArtVentive Endoluminal Occlusion System (EOS)-First in Human Clinical Trial. Cardiovasc Intervent Radiol. 2013 May 24. [Epub ahead of print]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033863"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Reduction of pain.", 
                "measure": "Pain", 
                "safety_issue": "No", 
                "time_frame": "Acute & 30 days"
            }, 
            {
                "description": "Recurrence of varices requiring repeat embolizations within 30 days.", 
                "measure": "Recurrent varices", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Sustained occlusion at 30 days follow-up.", 
                "measure": "Occlusion", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "ArtVentive Medical Group, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ArtVentive Medical Group, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "30 Days", 
        "verification_date": "January 2014"
    }
}